Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

AXSMAXSM

Showing 8 of 30 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in AXSOME THERAPEUTICS INC.

Yes. Northern Trust holds 270,189 shares of AXSM (Axsome Therapeutics), worth $66.1M, as of its Q2 2026 13F filing. It reduced the position by 131,270 shares (-32.7%) from Q1 2026. Northern Trust has held AXSM in every 13F on record since Q1 2019, 30 quarterly filings.

Current Value

$66.1M

Current Shares

270,189

Total Value Change

+$36.2M

Total Shares Change

-62,393

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
270,189
-32.7%
$66.1M0.0%$244.77
0
2026-Q1
Increased
401,459
+2.8%
$67.9M0.0%$169.02
30
2025-Q4
Decreased
390,431
-4.7%
$71.3M0.0%$182.64
0
2025-Q3
Increased
409,535
+0.0%
$49.7M0.0%$121.45
29
2025-Q2
Decreased
409,394
-0.4%
$42.7M0.0%$104.39
0
2025-Q1
Increased
410,969
+2.1%
$47.9M0.0%$116.63
30
2024-Q4
Increased
402,500
+21.0%
$34.1M0.0%$84.61
35
2024-Q3
Increased
332,582
+2.5%
$29.9M0.0%$89.87
29

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used